Prelude Capital Management, LLC Atai Life Sciences N.V. Transaction History
Prelude Capital Management, LLC
- $1.23 Billion
- Q1 2025
A detailed history of Prelude Capital Management, LLC transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, Prelude Capital Management, LLC holds 22,308 shares of ATAI stock, worth $45,954. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,308
Previous 35,341
36.88%
Holding current value
$45,954
Previous $47,000
36.17%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ATAI
# of Institutions
98Shares Held
23.7MCall Options Held
351KPut Options Held
170K-
Ubs Group Ag5.54MShares$11.4 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.29MShares$6.78 Million0.0% of portfolio
-
Pale Fire Capital Se Prague, 2N2.59MShares$5.34 Million0.42% of portfolio
-
Davidson Kempner Capital Management LP New York, NY1.41MShares$2.91 Million0.07% of portfolio
-
Black Rock Inc. New York, NY1.31MShares$2.69 Million0.0% of portfolio
About ATAI Life Sciences N.V.
- Ticker ATAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 165,875,008
- Market Cap $342M
- Description
- Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...